← 返回

GLP-1 Receptor Agonist and SGLT2 Inhibitor Use and Transcatheter Aortic Valve Replacement Outcomes: A Critique and Partial Re-Analysis.

期刊: The American journal of cardiology 日期: 2026-05-15 PMID: 41806961 浏览: 53
作者: Wang Joshua
Joshua, W. (2026). GLP-1 Receptor Agonist and SGLT2 Inhibitor Use and Transcatheter Aortic Valve Replacement Outcomes: A Critique and Partial Re-Analysis.. The American journal of cardiology.
Joshua W. GLP-1 Receptor Agonist and SGLT2 Inhibitor Use and Transcatheter Aortic Valve Replacement Outcomes: A Critique and Partial Re-Analysis.. The American journal of cardiology. 2026; PMID: 41806961
Joshua W. GLP-1 Receptor Agonist and SGLT2 Inhibitor Use and Transcatheter Aortic Valve Replacement Outcomes: A Critique and Partial Re-Analysis.[J]. The American journal of cardiology. 2026.
@article{joshua2026,
  author = {Wang Joshua},
  title = {GLP-1 Receptor Agonist and SGLT2 Inhibitor Use and Transcatheter Aortic Valve Replacement Outcomes: A Critique and Partial Re-Analysis.},
  journal = {The American journal of cardiology},
  year = {2026},
  note = {PMID: 41806961},
}
TY  - JOUR
AU  - Wang Joshua
TI  - GLP-1 Receptor Agonist and SGLT2 Inhibitor Use and Transcatheter Aortic Valve Replacement Outcomes: A Critique and Partial Re-Analysis.
T2  - The American journal of cardiology
PY  - 2026
AN  - PMID:41806961
ER  - 

摘要

AI 智能解读

相关文献

返回分类: 心血管
已选择 0 篇文献